Fecal microbial transplant after ileocolic resection reduces ileitis but restores colitis in IL-10 -/- Mice

Inflammatory Bowel Diseases

Volumn 21, Issue 7, 2015, Pages 1479-1490

  Perry, Troy ^a   Jovel, Juan ^a   Patterson, Jordan ^a   Wong, Gane ^a,b   Fedorak, Richard N ^a   Thiesen, Aducio ^a   Dicken, Bryan ^a   Madsen, Karen L ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b BGI SHENZHEN   (China)

Author keywords

colitis; Crohn's disease; dendritic cells; dysbiosis; metagenome

Indexed keywords

CD103 ANTIGEN; CD11B ANTIGEN; CXCL1 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BACTERIAL OVERGROWTH; CELL SUBPOPULATION; CLOSTRIDIA; COLITIS; CONTROLLED STUDY; DENDRITIC CELL; DYSBIOSIS; ENTEROCOCCUS; EPITHELIUM HYPERPLASIA; FECAL MICROBIAL TRANSPLANT; FECES ANALYSIS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GAMMAPROTEOBACTERIA; HISTOLOGY; ILEITIS; ILEOCOLIC RESECTION; IMMUNOCOMPETENT CELL; INTESTINE FLORA; LACTOBACILLUS; METAGENOME; MICROBIAL DIVERSITY; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMALL INTESTINE RESECTION; STREPTOCOCCUS; WILD TYPE; ANASTOMOSIS; ANIMAL; BACTERIAL TRANSLOCATION; COLON; COLON RESECTION; DEFICIENCY; DISEASE MODEL; FECES; GENETICS; ILEUM; MALE; MICROBIOLOGY; PROCEDURES; SURGERY;

ANASTOMOSIS, SURGICAL; ANIMALS; BACTERIAL TRANSLOCATION; COLECTOMY; COLITIS; COLON; DISEASE MODELS, ANIMAL; DYSBIOSIS; FECES; ILEITIS; ILEUM; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERLEUKIN-10; MALE; MICE; RNA;

EID: 84932164089     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000383     Document Type: Article

References (41)

1. Frolkis AD, Dykeman J, Negron ME, et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and metaanalysis of population-based studies. Gastroenterology. 2013;145:996-1006.
2. Rutgeerts P. Strategies in the prevention of post-operative recurrence in Crohn's disease. Best Pract Res Clin Gastroenterol. 2003;17: 63-73.
3. Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011;140:1729-1737.
4. Varol C, Zigmond E, Jung S. Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria. Nat Rev Immunol. 2010; 10:415-426.
5. Smythies LE, Sellers M, Clements RH, et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest. 2005;115:66-75.
6. Scott CL, Aumeunier AM, Mowat AM. Intestinal CD103+ dendritic cells: master regulators of tolerance?. Trends Immunol. 2011;32:412-419.
7. Novak ML, Koh TJ. Phenotypic transitions of macrophages orchestrate tissue repair. Am J Pathol. 2013;183:1352-1363.
8. Kühn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263-274.
9. Doyle J, Jewell L, Madsen K, et al. Intestinal histophathology in interleukin 10 gene knock out mice resembles Crohn's disease. In: Sutherland L, ed. Trends in Inflammatory Bowel Disease Therapy. Higham, MA: Kluwer Academic; 1997:281-284.
10. Berg DJ, Davidson N, Kuhn R, et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest. 1996;98: 1010-1020.
11. Madsen KL, Doyle JS, Tavernini MM, et al. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology. 2000;118: 1094-1105.
12. Rigby RJ, Hunt MR, Scull BP, et al. A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora. Gut. 2009;58:1104-1112.
13. Perry T, Borowiec A, Dicken B, et al. Murine ileocolic bowel resection with primary anastomosis. J Vis Exp. 2014.
14. Maharshak N, Packey CD, Ellermann M, et al. Altered enteric microbiota ecology in interleukin 10-deficient mice during development and progression of intestinal inflammation. Gut Microbes. 2013;4:316-324.
15. Borowiec AM, Sydora BC, Doyle J, et al. Small bowel fibrosis and systemic inflammatory response after ileocolonic anastomosis in IL-10 null mice. J Surg Res. 2012;178:147-154.
16. Mylonaki M, Rayment NB, Rampton DS, et al. Molecular characterization of rectal mucosa-Associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:481-487.
17. Geem D, Medina-Contreras O, Kim W, et al. Isolation and characterization of dendritic cells and macrophages from the mouse intestine. J Vis Exp. 2012:e4040.
18. Kielbasa SM, Wan R, Sato K, et al. Adaptive seeds tame genomic sequence comparison. Genome Res. 2011;21:487-493.
19. Huson DH, Mitra S. Introduction to the analysis of environmental sequences: metagenomics with MEGAN. Methods Mol Biol. 2012;856:415-429.
20. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.
21. Denning TL, Norris BA, Medina-Contreras O, et al. Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J Immunol. 2011;187:733-747.
22. Arner ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. 2000;267:6102-6109.
23. Fang F, Li Y, Bumann M, et al. Allelic variation of bile salt hydrolase genes in Lactobacillus salivarius does not determine bile resistance levels. J Bacteriol. 2009;191:5743-5757.
24. Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13:R79.
25. Ploger S, Stumpff F, Penner GB, et al. Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann N Y Acad Sci. 2012;1258: 52-59.
26. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146: 1489-1499.
27. Lech M, Grobmayr R, Weidenbusch M, et al. Tissues use resident dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon tissue injury: the immunoregulatory role of changing tissue environments. Mediators Inflamm. 2012;2012:951390.
28. Hogan BV, Peter MB, Shenoy HG, et al. Surgery induced immunosuppression. Surgeon. 2011;9:38-43.
29. Wu GJ, Tai YT, Chen TL, et al. Propofol specifically inhibits mitochondrial membrane potential but not complex I NADH dehydrogenase activity, thus reducing cellular ATP biosynthesis and migration of macrophages. Ann N Y Acad Sci. 2005;1042:168-176.
30. Ostanin DV, Bhattacharya D. Myeloid-derived suppressor cells in the inflammatory bowel diseases. Inflamm Bowel Dis. 2013;19:2468-2477.
31. Zhu X, Herrera G, Ochoa JB. Immunosuppression and infection after major surgery: a nutritional deficiency. Crit Care Clin. 2010;26: 491-500, ix.
32. Hartman AL, Lough DM, Barupal DK, et al. Human gut microbiome adopts an alternative state following small bowel transplantation. Proc Natl Acad Sci U S A. 2009;106:17187-17192.
33. Joly F, Mayeur C, Bruneau A, et al. Drastic changes in fecal and mucosaassociated microbiota in adult patients with short bowel syndrome. Biochimie. 2010;92:753-761.
34. Stephani J, Radulovic K, Niess JH. Gut microbiota, probiotics and inflammatory bowel disease. Arch Immunol Ther Exp (Warsz). 2011;59: 161-177.
35. Rooks MG, Veiga P, Wardwell-Scott LH, et al. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J. 2014;8:1403-1417.
36. Hogenauer C, Langner C, Beubler E, et al. Klebsiella oxytoca as a causative organism of antibiotic-Associated hemorrhagic colitis. N Engl J Med. 2006;355:2418-2426.
37. Bloom SM, Bijanki VN, Nava GM, et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe. 2011;9:390-403.
38. Persson EK, Scott CL, Mowat AM, et al. Dendritic cell subsets in the intestinal lamina propria: ontogeny and function. Eur J Immunol. 2013;43: 3098-3107.
39. Neut C, Bulois P, Desreumaux P, et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol. 2002;97:939-946.
40. Rutgeerts P, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2005;128:856-861.
41. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127:412-421.